VYNE THERAPEUTICS INC

VYNENASDAQ

🏆 #1920 by market capEarnings Aug 12US Equity

$28.56▲ $0.00 (+0.00%)

Market closed · at close

1h—

24h▲ 0.0%

7d▲ 13.6%

14d▲ 13.6%

30d▼ 13.0%

1y▲ 68.9%

🏦Market Cap

$954M

Small Cap

📈Revenue Growth (YoY)

+111.0%

High Growth

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

158.1x

Expensive

Otter Score

63

Fair

Earnings

Q3 · 2025Reported 2025-09-30

Earnings Per Share

Actual

-0.17

Expected

-0.13

miss

−28.20%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2025

-0.17

miss

Q2 2025

-0.13

beat

Q1 2025

-0.20

beat

Q4 2024

-0.28

beat